Press Releases

Researchers test drug combination of novel chemotherapeutic agent and PARP inhibitor in...

At the National Center for Tumor Diseases Dresden (NCT/UCC), children newly diagnosed...

Scientists at the National Center for Tumor Diseases Dresden (NCT/UCC) and Dresden...

Joint press release from National Center for Tumor Diseases...

Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) and the National Center...

The diagnosis of acute myeloid leukemia (AML) was previously considered a medical...

Press release of the NCT Heidelberg Cancer patients are particularly at risk for...

Scientists from the Biomedical Research Foundation of the Academy of Athens (Greece),...

Researchers of the Carl Gustav Carus University Hospital Dresden at the National Center...

National Center for Tumor Diseases Dresden begins several trials for new customized...